Clascoterone: all 25 studies that test it

Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• Comparison of Topical Clascoterone 1% Cream Versus Adapalene 0.1% Cream in the Treatment of Mild-to-Moderate Acne VulgarisRecruitingNCT07883538Not applicable
• Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial AcneNot yet recruitingNCT07881315Phase 4
• Comparison of Topical Clascoterone and Adapalene for Mild Acne VulgarisNot yet recruitingNCT07673094Early Phase 1
• 1% Clascoterone Cream for the Treatment Acne VulgarisNot yet recruitingNCT07457294Phase 3
• Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform RosaceaRecruitingNCT06952517Phase 2
• Efficacy and Safety of Clascoterone Cream 1% in Facial Acne VulgarisRecruitingNCT06403501Phase 3
• Topical Anti-Androgens in Pilonidal Sinus DiseaseRecruitingNCT06286397Phase 2
• A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With AcneCompletedNCT06415305Phase 4Results posted
• A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone PatientsCompletedNCT06415292Phase 4Results posted
• A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne PatientsCompletedNCT06415279Phase 4Results posted
• A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of AcneCompletedNCT06336629Phase 4Results posted
• A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of AcneCompletedNCT06336603Phase 4Results posted
• An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne VulgarisCompletedNCT02720627Phase 2Results posted
• An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne VulgarisCompletedNCT02682264Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)CompletedNCT02608476Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)CompletedNCT02608450Phase 3Results posted
• An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne VulgarisCompletedNCT01831960Phase 2Results posted
• A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne VulgarisCompletedNCT01631474Phase 2Results posted
• Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult SubjectsCompletedNCT06454708Phase 1
• A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne PatientsActive, not recruitingNCT06425900Phase 4
• A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)CompletedNCT05914805Phase 3
• A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair LossCompletedNCT05910450Phase 3
• Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone TherapyActive, not recruitingNCT05891795Phase 1/2
• A Study to Investigate the Effects of Cortexolone 17α-propionate (and Its Metabolites) on Healthy Volunteers' HeartCompletedNCT03665194Phase 1
• A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic AlopeciaCompletedNCT02279823Phase 2

← Clascoterone overview